ORIC-944
ORIC-944 is a potent, orally bioavailable, and selective PRC2 inhibitor designed for prostate cancer research. It demonstrates antitumor activity in both cellular assays and in vivo models, making it a valuable tool for investigating epigenetic mechanisms in oncology.
Product Specifications
CAS Number
2369769-29-7
Product Name Alternative
ORIC944
Field of Research
Epigenetics & Chromatin
Purity
98.08% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.23 mM) ; DMSO:80 mg/mL (175.24 mM)
Smiles
N#CC=1N=C2C (=CN=C (NCC=3C (F) =CC=C4OCCC43) N2C1) C5=CC=C (C=C5C) CN (C) C
Molecular Formula
C26H25FN6O
Molecular Weight
456.52
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1278127-01 0.01 mg Plasmid + 0.2 mL Glycerol-Stock
ASS1 cDNA Clone
Sign In for Pricing
View Details MBS1278127-02 5x 0.01 mg Plasmid + 5x 0.2 mL Glycerol-Stock
ASS1 cDNA Clone
Sign In for Pricing
View Details MBS7194514 Inquire
Rabbit anti-Arabidopsis thaliana (Mouse-ear cress) PME1 Polyclonal Antibody
Sign In for Pricing
View Details 
orb1079109 100 µL
Phospho-MAP2 (Thr1613/1619) Rabbit Polyclonal Antibody (RBITC)
Sign In for Pricing
View Details